baber/WOPTO huggingface dataset:
Patent AU-680997-B2 (AU)
Title: Medical dressing
Inventor: PLEWS JACQUELINE
IPC: A61M25/02
Filed: 1995-01-27
Granted: 1997-08-14
Abstract: PCT No. PCT/GB95/00164 Sec. 371 Date Dec. 5, 1996 Sec. 102(e) Date Dec. 5, 1996 PCT Filed Jan. 27, 1995 PCT Pub. No. WO95/20415 PCT Pub. Date Aug. 3, 1995There is described a cannula or catheter dressing comprising a body portion of flexible adherent sheet material for covering a wound site caused by the insertion of a catheter into a patient; and a handle an edge of which defines an aperture for receiving the catheter or cannula wherein the handle comprises a material less flexible than the body portion.
Patent AU-648228-B2 (AU)
Title: Heater arrangement for aluminum refining system
Inventor: PELTON JOHN FRANKLIN
IPC: F27B3/20
Filed: 1992-04-24
Granted: 1994-04-14
Abstract: A support plate, together with the shell of an aluminum holding and/or refining vessel, in combination with a refractory sheet positioned on the inner wall of a graphite block in which a heating element assembly is positioned, is used to hold and seal the heating assembly against exposure to air, without the need for enclosing the heating elements in a metal heating element container. <IMAGE>
Patent AU-783437-B2 (AU)
Title: Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
Inventor: GREIF GISELA
IPC: A61P33/02
Filed: 2000-11-21
Granted: 2005-10-27
Abstract: The present invention relates to the use of triazinones such as triazinediones and triazinetriones for triazinetriones for the preparation of compositions for treating animals, in particular treating animals prophylactically, against parasitic protozoans, and to these compositions.
Patent AU-609487-B2 (AU)
Title: Light-stabilized star polymer microparticles
Inventor: RODY JEAN
IPC: C09D153/00
Filed: 1988-06-06
Granted: 1991-05-02
Abstract: Light-stabilized star polymer microparticles are described which are prepared with particular advantage by group transfer polymerization. The light stabilization is effected by carrying out at least a part step of the polymerization in the presence of a light stabilizer, for example a hindered amine or/and a UV absorber. With particular advantage, those light stabilizers are used which contain reactive groups in the molecule and, in this way, can be chemically incorporated into the polymer. The polymer microparticles show excellent light stability and are outstandingly suitable as constituents in coating compositions which can be processed, for example, to give coating films of high light stability.
Patent AU-657535-B2 (AU)
Title: Electrical connectors
Inventor: WHITE ROWLAND SPENCER
IPC: H01R4/24
Filed: 1992-06-03
Granted: 1995-03-16
Abstract: An insulation displacement contact (10) comprises first and second contact portions each of which comprises a cantilevered split beam (19). The upper split beam, which receives insulated wires, comprises a pair of tynes (20,22) which are folded about the axis of a slot (25) separating the tynes such that the internal angle between the tynes is approximately 90°. The width of the tynes is larger than that of prior art devices resulting in increased stiffness and the length of the tynes is sufficiently long to receive two wires therebetween.The contacts (10) are mounted in a housing which includes a plurality of teeth (90) provided with means for retaining lugs (32,34) on the end of the tynes to ensure bowed opening of the tynes on insertion of a wire. The contacts are arranged along the central axis (72) of the housing such that the folded tynes of alternate contacts extend on opposite sides of the central axis.
Patent AU-731279-B2 (AU)
Title: Novel bridged cyclic amino acids as pharmaceutical agents
Inventor: HORWELL DAVID CHRISTOPHER
IPC: A61P25/28
Filed: 1997-02-18
Granted: 2001-03-29
Abstract: PCT No. PCT/US97/02401 Sec. 371 Date May 19, 1998 Sec. 102(e) Date May 19, 1998 PCT Filed Feb. 18, 1997 PCT Pub. No. WO97/33859 PCT Pub. Date Sep. 18, 1997Bridged cyclic amino acids of formula are disclosed and are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain and neuropathological disorders. Processes for the preparation and intermediates useful in the preparation are also disclosed.
Patent AU-719482-B2 (AU)
Title: Uses of GDNF and GDNF receptor
Inventor: KLEIN ROBERT D
IPC: A61K39/395
Filed: 1997-03-13
Granted: 2000-05-11
Abstract: GDNFRα, GDNFRα extracellular domain (ECD), GDNFRα variants, chimeric GDNFRα (e.g., GDNFRα immunoadhesin), and antibodies which bind thereto (including agonist and neutralizing antibodies) are disclosed. Various uses for these molecules are described, including methods to modulate cell activity and survival by response to GDNFRα-ligands, for example GDNF, by providing GDNFRα to the cell. Also provided are methods for using GDNFRα, GDNF, or agonists thereof, separately or in complex, to treat kidney diseases.
Patent AU-652071-B2 (AU)
Title: In vivo delivery of active factors by co-cultured cell implants
Inventor: AEBISCHER PATRICK
IPC: C12N11/00
Filed: 1992-06-25
Granted: 1994-08-11
Abstract: Methods and devices are disclosed for the delivery of an active factor from an implanted co-culture of an active factor-secreting cell obtained from a first source and an augmentary substance-secreting cell obtained from a second source different from the first source, to a target region in a subject. The co-culture is maintained within a biocompatible, semipermeable membrane in which the augmentary substance secreted by the augmentary substance-producing cells stimulates the active factor-producing cells to secrete active factor. The semipermeable membrane permits the diffusion of the active factor therethrough while excluding detrimental agents present in the extenral environment from gaining access to the co-culture.
Patent AU-687198-B2 (AU)
Title: Method and apparatus for am compatible digital broadcasting
Inventor: DAPPER MARK JAMES
IPC: H04L27/34
Filed: 1995-02-27
Granted: 1998-02-19
Abstract: A broadcasting method for simultaneously broadcasting analog and digital signals in a standard AM broadcasting channel is provided by: broadcasting an amplitude modulated radio frequency signal having a first frequency spectrum, wherein the amplitude modulated radio frequency signal includes a first carrier modulated by an analog program signal; and simultaneously broadcasting a plurality of digitally modulated carrier signals within a bandwidth which encompasses the first frequency spectrum, each of the digitally modulated carrier signals being modulated by a portion of a digital program signal, wherein a first group of the digitally modulated carrier signals lying within the first frequency spectrum are modulated in-quadrature with the first carrier signal, and wherein second and third groups of the digitally modulated carrier signals lie outside of the first frequency spectrum and are modulated both in-phase and in-quadrature with the first carrier signal. Transmitters and receivers which operate in accordance with the above method are also provided.
Patent AU-693223-B2 (AU)
Title: Taxoids, preparation and pharmaceutical compositions containing them
Inventor: BOUCHARD HERVE
IPC: C07D305/14
Filed: 1995-06-07
Granted: 1998-06-25
Abstract: PCT No. PCT/FR95/00736 Sec. 371 Date Dec. 6, 1996 Sec. 102(e) Date Dec. 6, 1996 PCT Filed Jun. 7, 1995 PCT Pub. No. WO95/33737 PCT Pub. Date Dec. 14, 1995This invention relates to taxoids of the formula (I):    <IMAGE>  (I)  a method for preparing these taxoids, and pharmaceutical compositions containing them. In formula (I), R is alkyl radical (1-6 carbon atoms), alkenyl (2-6 carbon atoms), alkynyl (2-6 carbon atoms), cycloalkyl (3-6 carbon atoms), cycloalkenyl (4-6 carbon atoms), phenyl, unsaturated heterocyclyl containing from 5 to 6 links, Z is a hydrogen atom or a radical of formula (II):stituted benzoyl radical, thenoyl radical, furoyl radical, or a radical R2-O-CO- in which R2 is an alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, optionally substituted phenyl or heterocyclyl, and R3 is an alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, naphthyl or aromatic heterocyclic radical. The taxoids of formula (I) in which Z is a radical of formula (II) have remarkable antitumoral and antileukemic properties.
Patent AU-615701-B2 (AU)
Title: High definition video signal processing
Inventor: VREESWIJK FRANCISCUS WILHELMUS
IPC: H04N7/24
Filed: 1988-12-29
Granted: 1991-10-10
Abstract: A transmitting section of the system according to the invention has transmitting section signal paths for at least three classes of motion, each with a preprocessing circuit (143, 145 and 147) which are provided with means for individually sampling. These sampling means sample in accordance with separate sampling patterns so that each preprocessing circuit (143, 145 or 147) supplies a video signal which is suitable for a display with an optimum distribution of temporal and/or spatial resolution for the associated class of motion. Dependent on the class of motion determined, one of the preprocessing circuits (143, 145 or 147) is coupled to a channel (170). The video signal to be supplied to the channel (170) is therefore a video signal suitable for a display with an optimum distribution of temporal and/or spatial resolution for the given class of motion (Fig. 1A). A normal-definition MAC receiver is capable of displaying the compatible transmitted video signal, but without being able to make use of the possibility of a display with a higher spatial resolution in the case of little or no motion. A high-definition receiving section of the system according to the invention also has at least three receiving section signal paths comprising a postprocessing circuit (43, 45 and 47) which decodes a received video signal in accordance with a method associated with the relevant postprocessing circuit (43, 45 or 47). The correct postprocessing circuit (43, 45 or 47) is selected in accordance with the class of motion, so that in the receiving section of the system according to the invention a display with an increasing spatial resolution can be achieved in the case of a decreasing motion
Patent AU-659234-B2 (AU)
Title: HIV protease inhibitors useful for the treatment of AIDS
Inventor: VACCA JOSEPH P
IPC: A61K31/16
Filed: 1992-11-06
Granted: 1995-05-11
Abstract: Cpds. of formula (I) and their salts are new. In the formula X = OH or NH2; Z = O, S or NH; R = H or 1-4C alkyl; R1,R2 = e.g. H, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl (opt. substd. by 1 or more from 1-4C alkyl, OH and aryl), -w-aryl, -w-benzyl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl etc, or R1+N+R2 = eg. 3-10 member satd. monocyclic or bicyclic ring contg. 2-9C (opt. substd. by OH, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl), heterocycle and NR2) etc., or R1+N+R2 = eg. 3-10 member satd. monocyclic or bicyclic ring contg. 2-9C (opt. substd. by OH, 1-4C alkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy, aryl, 5-7C cycloalkyl (opt. substd. by 1 or more from halo, OH, 1-3C alkoxy and aryl), heterocycle and NR2) etc., or R1+N+R2 = 3-10 member satd. monocyclic or bicyclic ring contg. 1-8C and 1 or more additional heteroatom (opt. substd.), or R1+N+R2 = 3-10C member satd. monocyclic or bicyclic ring contg. 209C, fused to Ph (opt. substd. by 1 or more from halo, 1-3C alkoxy, OH, 1-4C alkyl, NHR, (where R1 is not joined to R2) and NH-heterocycle; R3 = (CH2)R4, 1-4C alkenyl-R4 or 1-4C alkynyl R4; R4 = eg. H, 1-4C alkyl, 5-10 cycloalkyl (opt. substd. by OH), 6-10C aryl (opt. substd. by 1 or more from halo, OH, NO2, NR2, 1-4C, 1-3C alkoxy (opt. substd. by 1 or more from OH and 1-3C alkoxy), CO2R, CONR2, CH2NR2, CH2NHCOR, CN, CF3, NHCOR etc, B = absent or -NH-CH(R8)-C(=Z)-; J1,J2 = -YR9, N(R9)2, NR10R11 or -Y(CR9R12)n-R12; W = O, S or NH; n = 0-3; R8 = CHMe2, CH(me)Et or Ph; Y = O or NH; R9 = eg. H, 1-6C alkyl (opt. substd. by 1 or more from NR2, OR, NHSO2 (1-4Calkyl), NHSO2 aryl, NHSO2 (dialkylaminoaryl) etc., R10+N+R11 = 5-7 member heterocycle opt. contg. 1 additional heteroatom O, S or NR); R12 = eg. H, aryl (opt. substd. by 1 or more from R14, -1-4C alkyl-NR2 and OCO(1-4Calkyl) etc.. R14 = halo, OR, CONR2, CH2NR2, SO2NR2, NR2, NHCOR, 1-4alkyl, Ph, CF3, N(R)SO2R, OP(O)(ORx)2 or CO2R.
Patent AU-658257-B2 (AU)
Title: Nuclear matrix protein fluid assay
Inventor: BEAUSANG LEE ANNE
IPC: G01N33/50
Filed: 1992-10-29
Granted: 1995-04-06
Abstract: Disclosed is a method for detecting and quantitating soluble nuclear matrix proteins in body fluids and extracellular media. The method is useful for monitoring the viability of cells and tissue, for evaluating the progress of a disease or its treatment, and for evaluating the cytotoxicity of unknown compounds. Also disclosed are methods for inducing the release of nuclear matrix proteins in soluble form from cells.
Patent AU-770903-B2 (AU)
Title: Nucleic acid encoding hyaluronan synthase and methods of use
Inventor: DEANGELIS PAUL
IPC: C12Q1/68
Filed: 1999-04-01
Granted: 2004-03-04
Abstract: The present invention relates to a nucleic acid segment having a coding region segment encoding enzymatically active  bacterial multocida , and to the use of this nucleic acid segment in the preparation of recombinant cells which produce chondroitin synthase and chondroitin polymer.
Patent AU-659929-B2 (AU)
Title: Enantioselective oxazaborolidine catalysts
Inventor: QUALLICH GEORGE J
IPC: C07C35/32
Filed: 1993-02-01
Granted: 1995-06-01
Abstract: The borane reduction of prochiral ketones to optically pure alcohols is effectively achieved by the utilization of catalytic amounts of the new and valuable oxazaborolidine catalysts of formula (I).
Patent AU-617871-B2 (AU)
Title: In position 3 substituted-5-beta-amidomethyl-oxazolidin-2- ones
Inventor: BRICKNER STEVEN J
IPC: C07D413/04
Filed: 1989-08-22
Granted: 1991-12-05
Abstract: of formulae (XI) and (XIII), 3-(fused ring substd.)phenyl-5 beta -(amidomethyl)oxazolidin-2-ones of formula (XXI), and 3-(N-substd.)phenyl-5 beta (aminodimethyl)oxazolidin-2-ones of formula (IV), and their salts are new: where in (XI); R1 = e.g. H, 1-12C alkyl (opt. substd. with 1-3 Cl), 3-12C cycloalkyl, 5-12C monosubstd. alkenyl, phenyl furanyl, tetrahydrofuranyl or 2-thiophene etc. 2 of R2, R3, R4 = H and the other = e.g. H, F, Cl, Br, I or 1-6C alkyl etc. R5 = e.g. H, 1-12C alkyl, benzyl, phenethyl, 3-7C cycloalkyl, 2-12C alkenyl contg. 1-3 double bonds, 2-12C alkynyl contg. 1 triple bond, -CHO etc. in (XIII), X1 = Ac, -COOtBn, -COOCH2Ph or -COO(CH2)2SiMe3; R2, R3, R4 = as above; and R6 = I, N3 or NH2; in (XXI), R1 = as above; R2 or R4 = H and the other together with R3 is -(CH2)n3-(CR10-1R10-2)n7 -CO-(CR10-3R10-4)n8-(CH2)n4-, -(CH2)n5-CH=CH-(CH2)n6- or -(CH2)n3-(CR10-1 R10-2)n7-C(:NOR7)-(CR10-3R10-4)n8-(CH2)n4-; n3, n4 = 0-3; n7, n8 = 0 or 1; R10-1, R10-2 = H or 1-3C alkyl or together complete spirocyclopropyl; R10-3, R10-4 = H or 1-3C alkyl or together complete spirocyclopropyl; with the provisos that (1) n7 + n8 = 1 or (b) n7 = 1 and one of R10-1 or R10-2 is not H; n5, n6 = 0-2; n5 + n6 = 1 or 2; R7 = H, 1-4C alkyl, -CH2COOH or -CH2COOR7-1; R7-1 = 1-4C alkyl; R5 or R6 = H and the other is as for R5 in (XI) above; in (IV), R1, R2, R3, R4 = as in (XI); W1 and W2 together = -NR5-N=CR'6-, -NR5-CR''6=N-or -NR5-N=N-; and R5 = as in (XI); R'6 = H or 1-3C alkyl; and R''6 = H, 1-6C alkyl, SH, SMe, Set, SPh, SOMe, SOPh, SO2Me or SO2Ph.
Patent AU-645483-B2 (AU)
Title: Detection of human papillomavirus by the polymerase chain reaction
Inventor: MANOS M MICHELE
IPC: C12Q1/68
Filed: 1989-08-29
Granted: 1994-01-20
Abstract: PCT No. PCT/US89/03747 Sec. 371 Date Feb. 5, 1991 Sec. 102(e) Date Feb. 5, 1991 PCT Filed Aug. 29, 1989.The presence of human papillomavirus (HPV) in a sample can be detected and the HPV typed by a method that involves the amplification of HPV DNA sequences by the polymerase chain reaction (PCR). The primers used in the method are consensus primers that can be used to amplify a particular region of the genome of any HPV. The presence of HPV in a sample is indicated by the formation of amplified DNA. The HPV is typed by the use of type-specific DNA probes specific for the amplified region of DNA.
Patent AU-771905-B2 (AU)
Title: Method for producing mononatrium trihydrogen pyrophosphate
Inventor: KLEIN THOMAS
IPC: C01B25/42
Filed: 2000-05-04
Granted: 2004-04-08
Abstract: The invention relates to a novel method for producing mononatrium trihydrogen pyrophosphate and to the use of products produced by said method as acidifiers, buffering agents and complexing agents. The novel method is characterised in that glassy, acidic natrium polyphosphate containing a Na/P ratio of 1: 2 in fine powder form is tempered at temperatures ranging between 100 and 200  DEG C in moist air with a steam pressure of between 10 and 200 mBar, or in a polar solvent, in which the phosphate is insoluble, in the presence of a quantity of water sufficient for the hydrolysis, until the mass has been predominantly converted into NaH3P2O7.
Patent AU-574509-B2 (AU)
Title: Continuous laminated paper
Inventor: GOLDSTEIN GUY
IPC: B32B3/08
Filed: 1985-09-02
Granted: 1988-07-07
Abstract: PCT No. PCT/FR85/00235 Sec. 371 Date Jun. 16, 1986 Sec. 102(e) Date Jun. 16, 1986 PCT Filed Sep. 2, 1985 PCT Pub. No. WO86/01389 PCT Pub. Date Mar. 13, 1986.A laminated web for use as a roll towel comprises a sheet of plastics scrim 2 between two layers of tissue paper 1. The edge portions of the towel are reinforced with plastics tapes 3 and threads 4. The tapes 3 prevent tearing of the towel across its width while the threads resist bursting of the towel in the regions normally grasped by a user.
Patent AU-662448-B2 (AU)
Title: Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine N-oxides, processes for their preparation and their use as medicaments
Inventor: WEIDMANN KLAUS
IPC: C07D213/89
Filed: 1993-10-01
Granted: 1995-08-31
Abstract: The invention relates to acylsulphonamido- and sulphonamidopyridine-2-carboxylic acid esters and their pyridine-N-oxides of the general formula I <IMAGE>  in which     A = R<3> and B = X-NR<5>R<6> or   B = R<3> and A = X-NR<5>R<6>.   The compounds are suitable as medicaments against fibrotic diseases.
Patent AU-630662-B2 (AU)
Title: A cassette loading mechanism for a recording and reproducing apparatus
Inventor: TOYOGUCHI TSUTOMU
IPC: G11B15/675
Filed: 1990-02-08
Granted: 1992-11-05
Abstract: A recording and/or reproducing apparatus for recording and/or reproducing information signals with the use of a tape cassette (300) is provided with a pair of reel shafts (6, 7), each having an engaging member (6b, 7b) mounted with a bias towards the end of the supporting shaft, and a tape cassette transfer mechanism adapted for shifting the tape cassette inserted by way of the cassette inserting opening (2a) in a first direction normal to the reel shafts and guiding or loading the tape cassette for inserting and engaging the reel shafts with a pair of tape reels (302, 303) within the tape cassette. When at least the tape cassette transfer mechanism is set at a position facing the cassette inserting opening, the tape cassette is moved by the tape cassette transfer mechanism towards the proximal side of reel shafts, to reduce the displacement in the second direction of the tape reel of the tape cassette by the tape cassette transfer mechanism to a value lesser than the thickness of the tape cassette to reduce the thickness of the apparatus. After completion of the tape cassette loading by the tape cassette transfer mechanism, the tape cassette is partially exposed to the cassette inserting opening to prevent a second tape cassette from being introduced into the cassette inserting opening after completion of loading of the first-mentioned cassette.
Patent AU-761807-B2 (AU)
Title: Method and apparatus for marking containers using laser light
Inventor: MILLER TIMOTHY J
IPC: B23K26/08
Filed: 1999-07-15
Granted: 2003-06-12
Abstract: A portion or component of a metal container is provided with markings or indicia using laser light. High-speed laser steering is used to position laser light or laser light pulses across a lateral and longitudinal extent in a relatively short time period such as a time period selected so as to avoid slowing, stopping or otherwise interfering with other container or container component production processes. Preferably, tab stock for container-opening tabs can be provided with 6 to 9 or more visible characters within a time window of 50 to 100 milliseconds or less. Preferably, the size and resolution provided by the pulses are sufficient to permit legible, and preferably attractive, formation of any standard typewriter characters. In one embodiment, other logos, designs, textures, backgrounds and similar features can be provided.
Patent AU-631414-B2 (AU)
Title: Combined rigid profile and strain roof bolt with expansion element
IPC: E21D21/00
Filed: 1990-04-09
Granted: 1992-11-26
Abstract: In rock anchors, in particular combined rigid profile and extension anchors, the anchor rod (1), except for the anchor tip (2), is surrounded by an envelope tube (3), and its end projecting from the mouth of the drilled hole is designed so that it can be restrained relative to the rock by means of an anchor plate and a screw connection. In order to guarantee the immediate bearing capacity of an anchor of this type, in particular in the filling-mortar method, at least one section (5) of the envelope tube (3) is provided with recesses (7) as an  expanding element, which recesses (7) are distributed over the periphery and the length and are integrated in slots (8), and the anchor tip (2) is designed as an abutment. 
<IMAGE>
Patent AU-758019-B2 (AU)
Title: Anthrax vaccine
Inventor: LEE JOHN S
IPC: C07K14/32
Filed: 1999-07-09
Granted: 2003-03-13
Abstract: Using nucleic acids encoding mutant SEA and SEB exotoxins from Staphylococcus aureus, compositions and methods for use in inducing an immune response which is protective against staphylococcal aureus intoxication in subjects is described.
Patent AU-676247-B2 (AU)
Title: Trocar safety shield locking mechanism
Inventor: SMITH RICHARD C
IPC: A61B17/34
Filed: 1994-02-25
Granted: 1997-03-06
Abstract: A trocar and trocar obturator assembly having an obturator and a locking mechanism responsive to proximal, axial movement of the trocar obturator is disclosed. The trocar obturator has an elongated obturator shaft having a proximal end and a distal end with a piercing tip mounted thereto. The proximal end of the trocar obturator shaft is slidably mounted in a handle such that the obturator shaft is moveable axially. A protective safety shield having a distal end and a proximal end with a flange member mounted to the proximal end is slidably mounted on the trocar obturator. The safety shield is moveable, axially, between an extended distal position and a retracted proximal position. The protective safety shield is disposed concentrically about the obturator. A lockout arm for locking the safety shield in a locked extended position is mounted in the trocar obturator handle. An actuating collar member is mounted to the proximal end of the obturator shaft in the obturator handle and is moveable with the obturator shaft. The obturator collar disengages the locking arm when moved proximally and engages the locking arm when trocar is armed. The trocar obturator assembly may be concentrically mounted in a trocar cannula having a passageway for receiving the trocar obturator and safety shield. The locking mechanism is actuated by proximal, axial motion of the obturator.